A Retrospective Non-interventional Study of Breast Cancer Patients Diagnosed With HR+/HER2- Locally Advanced or Metastatic Breast Cancer Treated With Palbociclib in Denmark
Clinical trial NCT05452798 · COMPLETED
Trial details
- NCT number
- NCT05452798
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-02-01
- Primary completion
- 2022-08-01
- Enrollment
- 1054
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.